A topical cosmetic hexapeptide often called "topical Botox" — it mimics the SNAP-25 protein to interfere with SNARE-complex assembly, modestly reducing the muscle contractions behind dynamic expression lines.
Last Updated: July 2026
Argireline is the trade name for acetyl hexapeptide-8 (formerly acetyl hexapeptide-3 — both names appear for the identical molecule), a synthetic six-amino-acid peptide developed by Lipotec (now Lubrizol) around 2000 as a topical alternative to injectable neuromodulators. Its sequence is Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂. It is a widely used cosmetic ingredient in anti-aging skincare — not an approved drug.
Argireline reproduces the N-terminal end of SNAP-25 and competes with native SNAP-25 for its place in the SNARE complex — the protein machinery that lets nerve endings release acetylcholine — so a less-efficient complex means reduced neurotransmitter release and gentler contraction of the small facial muscles that etch expression lines. This is why it's nicknamed "topical Botox," though the mechanism differs fundamentally from botulinum toxin, which enzymatically and irreversibly cleaves SNAP-25 after injection for a far stronger, longer effect.
Controlled cosmetic studies support a modest anti-wrinkle effect: the original 2002 study reported roughly a 30% reduction in wrinkle depth from a 10% cream over 30 days versus placebo, and a later randomized placebo-controlled study in Chinese subjects found measurable improvement — but effects are modest, the peptide penetrates skin poorly, and some visible benefit may come from a formulation's hydration rather than SNAP-25 inhibition. Read the "erases wrinkles" marketing critically. Evidence level: Small cosmetic RCTs / in-vitro; effects modest.
Topical Argireline is generally well tolerated at cosmetic concentrations (5–10%), with infrequent mild local irritation, and minimal systemic exposure because it penetrates poorly — it is a cosmetic ingredient rather than an approved drug, so a patch test is sensible and pregnancy/breastfeeding safety data are limited. It is not a substitute for, or equivalent to, injectable neuromodulators.
Argireline is sold as a raw peptide for formulation as well as in finished products, and identity/purity of the raw material vary between suppliers — HPLC purity and mass-spec identity confirm the vial contains the correct hexapeptide at the labeled amount. Peptigrity buys the raw peptide anonymously, tests it at independent ISO-accredited labs, and publishes the unedited COA; the trust score weights lab purity and reviews equally (50/50). See how to read lab results.
Educational information only; not medical or skincare advice. Argireline is a cosmetic ingredient, not an approved drug — patch-test before use and consult a professional if pregnant, breastfeeding, or if you have sensitive skin. Peptigrity does not sell, endorse, or recommend products or vendors.
Real protocols and questions from members — independent of vendors, never sponsored.
Sign in to ask a question.
Every submitted test helps the community verify purity across brands. Free, fast, independent.